CDC Issues Alert On Severe Arboviral Risk With B-Cell Therapies
XLV•CDC issues health advisory on arboviral risk
- CDC: issuing a health advisory for risk of severe arboviral disease in patients receiving B cell-depleting or modulating medications
- CDC: there are no approved treatments, prophylactic agents, or human vaccines to prevent arboviral diseases endemic to the United States
